Sign in to view content

Faricimab Response is Associated With Intraocular Pressure Lowering in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration

Tamara L Lenis, MD, PhD, FASRS

Video
Published 2024

Related

Update on Faricimab for DME: New Clinical Features of Eyes in the RHONE-X Long-Term Extension Study
Veeral S. Sheth, MD, MBA, FASRS, FACS
Annual Meeting Talks
2025
Switching to Combination OPT-302 With Aflibercept From Prior Anti-VEGF-A Monotherapy in Eyes With Persistent Diabetic Macula Edema (DME)
David S. Boyer, MD
Annual Meeting Talks
2020
Pigment Epithelial Detachment Outcomes With Faricimab vs Aflibercept in Patients With nAMD: Results From TENAYA/LUCERNE
Aude Ambresin, MD, PD
Annual Meeting Talks
2024

Category: Diabetic Retinopathy

See more